Lars Møller Pedersen

6.7k citations
103 papers · 3.4k · 2 hit papers · h-index 28

Impact in

Papers in

Lars Møller Pedersen

95 papers receiving 3.3k citations

Lars Møller Pedersen's Hit Papers

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone 2012 · 484 citations
4840+7+14Years since publication100200300400

Peers

Lars Møller Pedersen
Comparison fields: 5 of 101
  • Pathology and Forensic Medicine 1.9k
  • Genetics 823
  • Oncology 1.1k
  • Neurology 438
  • Radiology, Nuclear Medicine and Imaging 552
Replace Gustaaf W. van Imhoff with:
Gustaaf W. van Imhoff Netherlands
Louis F. Diehl United States
Mars B. vanʼt Veer Netherlands
Sergio Cortelazzo Italy
M. Monconduit France
Kerry L. Reynolds United States
Paul Hoskins Canada
Petr Starostik United States
Dominic Culligan United Kingdom
M Leporrier France
Lars Møller Pedersen relative to Gustaaf W. van Imhoff Netherlands Gustaaf W. van Imhoff's profile →
Citations per field
00.5×3.2×
Gustaaf W. van Imhoff · 1×
Citations per year

Countries citing papers authored by Lars Møller Pedersen

Since Specialization
Citations

This map shows the geographic impact of Lars Møller Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Møller Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Møller Pedersen more than expected).

Fields of papers citing papers by Lars Møller Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Møller Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Møller Pedersen. The network helps show where Lars Møller Pedersen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Møller Pedersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Møller Pedersen Line = papers co-authored together Lars Møller Pedersen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
Hit paper breakdown →
2005497
2
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Hit paper breakdown →
2012484
3 2007287
4 2008203
5 1996201
6
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
2006165
7 2002102
8 201496
9 200992
10 201290
11 201358
12 201153
13 201548
14 200546
15 200346
16 201545
17 199544
18 201039
19 201238
20 201738

About Lars Møller Pedersen

Lars Møller Pedersen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 103 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (55 papers), Chronic Lymphocytic Leukemia Research (24 papers), Viral-associated cancers and disorders (15 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers), MRI in cancer diagnosis (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Genetics (823 citations), Oncology (1.1k citations), Neurology (438 citations) and Radiology, Nuclear Medicine and Imaging (552 citations). Lars Møller Pedersen has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Nils Milman, Ole Gadeberg, Francesco d’Amore, Michael Møller, Martin Hutchings, Anne Kiil Berthelsen, Lena Specht, Mads Hansen, A. M. Boesen and Susanne Keiding. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Oncology, Journal of Clinical Oncology and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact